Transgenomic Price to Sales Ratio 2010-2023 | PRPO
Historical PS ratio values for Transgenomic (PRPO) over the last 10 years. The current P/S ratio for Transgenomic as of May 03, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Transgenomic P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-03 |
5.80 |
|
0.49 |
| 2023-12-31 |
6.50 |
$11.90 |
0.55 |
| 2023-09-30 |
5.61 |
$10.67 |
0.53 |
| 2023-06-30 |
7.80 |
$9.38 |
0.83 |
| 2023-03-31 |
13.28 |
$8.55 |
1.55 |
| 2022-12-31 |
11.03 |
$8.28 |
1.33 |
| 2022-09-30 |
16.08 |
$8.49 |
1.89 |
| 2022-06-30 |
21.20 |
$8.52 |
2.49 |
| 2022-03-31 |
27.00 |
$8.67 |
3.11 |
| 2021-12-31 |
31.60 |
$8.56 |
3.69 |
| 2021-09-30 |
56.40 |
$8.60 |
6.56 |
| 2021-06-30 |
72.60 |
$8.66 |
8.38 |
| 2021-03-31 |
46.20 |
$8.73 |
5.29 |
| 2020-12-31 |
41.40 |
$9.60 |
4.31 |
| 2020-09-30 |
49.00 |
$9.66 |
5.07 |
| 2020-06-30 |
28.40 |
$10.16 |
2.80 |
| 2020-03-31 |
14.00 |
$11.19 |
1.25 |
| 2019-12-31 |
41.00 |
$12.42 |
3.30 |
| 2019-09-30 |
52.20 |
$19.51 |
2.68 |
| 2019-06-30 |
67.60 |
$25.37 |
2.66 |
| 2019-03-31 |
37.50 |
$33.85 |
1.11 |
| 2018-12-31 |
46.20 |
$46.70 |
0.99 |
| 2018-09-30 |
118.56 |
$98.16 |
1.21 |
| 2018-06-30 |
110.34 |
$100.65 |
1.10 |
| 2018-03-31 |
161.16 |
$225.69 |
0.71 |
| 2017-12-31 |
360.00 |
$374.03 |
0.96 |
| 2017-09-30 |
648.00 |
$754.49 |
0.86 |
| 2017-06-30 |
2700.00 |
$986.94 |
2.74 |
| 2017-03-31 |
6030.00 |
$1,210.10 |
4.98 |
| 2016-12-31 |
2557.80 |
$1,147.37 |
2.23 |
| 2016-09-30 |
2538.00 |
$996.66 |
2.55 |
| 2016-06-30 |
4950.00 |
$973.32 |
5.09 |
| 2016-03-31 |
5252.40 |
$953.32 |
5.51 |
| 2015-12-31 |
9630.00 |
$1,600.71 |
6.02 |
| 2015-09-30 |
8308.80 |
$-18,488.75 |
0.00 |
| 2015-06-30 |
15030.00 |
$-13,628.75 |
0.00 |
| 2015-03-31 |
12960.00 |
$-5,513.75 |
0.00 |
| 2014-12-31 |
18090.00 |
$1,550.00 |
11.67 |
| 2014-09-30 |
33930.00 |
$29,121.25 |
1.17 |
| 2014-06-30 |
33660.00 |
$32,348.75 |
1.04 |
| 2014-03-31 |
41220.00 |
$33,026.25 |
1.25 |
| 2013-12-31 |
49680.00 |
$34,430.00 |
1.44 |
| 2013-09-30 |
41040.00 |
$38,810.83 |
1.06 |
| 2013-06-30 |
43200.00 |
$30,503.44 |
1.42 |
| 2013-03-31 |
43200.00 |
$21,371.07 |
2.02 |
| 2012-12-31 |
65880.00 |
$12,153.69 |
5.42 |
| 2012-09-30 |
102599.99 |
$17,142.35 |
5.99 |
| 2012-06-30 |
97200.00 |
$17,142.41 |
5.67 |
| 2012-03-31 |
129599.99 |
$17,142.44 |
7.56 |
| 2011-12-31 |
139319.99 |
$17,142.47 |
8.13 |
| 2011-09-30 |
139319.99 |
$0.58 |
241048.47 |
| 2011-06-30 |
188999.99 |
$0.50 |
377758.62 |
| 2011-03-31 |
95040.00 |
$0.45 |
211978.89 |
| 2010-12-31 |
71280.00 |
$0.41 |
175034.90 |
| 2010-09-30 |
43200.00 |
$0.44 |
99020.06 |
| 2010-06-30 |
52920.00 |
$0.45 |
117808.39 |
| 2010-03-31 |
92880.00 |
$0.46 |
203273.13 |
| 2009-12-31 |
74520.00 |
$0.45 |
166445.93 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.009B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
